162 related articles for article (PubMed ID: 38609892)
1. A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
Yang Y; Yi Y; Wang Z; Li S; Zhang B; Sang Z; Zhang L; Cao Q; Li B
BMC Cancer; 2024 Apr; 24(1):460. PubMed ID: 38609892
[TBL] [Abstract][Full Text] [Related]
2. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of systemic immune-inflammation index for pathological complete response in patients receiving neoadjuvant immunochemotherapy for locally advanced esophageal cancer.
Han W; Weng K; Zhang P; Hong Z
Front Surg; 2022; 9():1091601. PubMed ID: 36684142
[TBL] [Abstract][Full Text] [Related]
4. Radiomics-clinical nomogram for preoperative lymph node metastasis prediction in esophageal carcinoma.
Geng X; Zhang Y; Li Y; Cai Y; Liu J; Geng T; Meng X; Hao F
Br J Radiol; 2024 Feb; 97(1155):652-659. PubMed ID: 38268475
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Prediction of Perineural Invasion in Oesophageal Squamous Cell Carcinoma Based on CT Radiomics Nomogram: A Multicenter Study.
Zhou H; Zhou J; Qin C; Tian Q; Zhou S; Qin Y; Wu Y; Shi J; Feng F
Acad Radiol; 2024 Apr; 31(4):1355-1366. PubMed ID: 37949700
[TBL] [Abstract][Full Text] [Related]
6.
Wang S; Di S; Lu J; Xie S; Yu Z; Liang Y; Gong T
Thorac Cancer; 2023 Aug; 14(24):2338-2349. PubMed ID: 37424279
[TBL] [Abstract][Full Text] [Related]
7. A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma.
Yang Y; Xin D; Wang H; Guan L; Meng X; Lu T; Bai X; Wang F
J Inflamm Res; 2023; 16():1443-1455. PubMed ID: 37042015
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
Front Oncol; 2020; 10():1398. PubMed ID: 32850451
[No Abstract] [Full Text] [Related]
9. Radiomics Nomogram with Added Nodal Features Improves Treatment Response Prediction in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study.
Li K; Zhang S; Hu Y; Cai A; Ao Y; Gong J; Liang M; Yang S; Chen X; Li M; Tian J; Shan H
Ann Surg Oncol; 2023 Dec; 30(13):8231-8243. PubMed ID: 37755566
[TBL] [Abstract][Full Text] [Related]
10. Predictive nomogram for postoperative atrial fibrillation in locally advanced esophageal squamous carcinoma cell with neoadjuvant treatment.
Fang M; Chen M; Du X; Chen S
Front Surg; 2022; 9():1089930. PubMed ID: 36684273
[TBL] [Abstract][Full Text] [Related]
11. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
[TBL] [Abstract][Full Text] [Related]
12. A radiomics nomogram based on contrast-enhanced CT for preoperative prediction of Lymphovascular invasion in esophageal squamous cell carcinoma.
Wang Y; Bai G; Huang W; Zhang H; Chen W
Front Oncol; 2023; 13():1208756. PubMed ID: 37465108
[TBL] [Abstract][Full Text] [Related]
13. Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma.
Xu L; Wei XF; Li CJ; Yang ZY; Yu YK; Li HM; Xie HN; Yang YF; Jing WW; Wang Z; Kang XZ; Zhang RX; Qin JJ; Xue LY; Bi N; Chen XK; Li Y
Front Immunol; 2022; 13():1052542. PubMed ID: 36466925
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Biomol Biomed; 2023 Feb; 23(1):153-160. PubMed ID: 35880397
[TBL] [Abstract][Full Text] [Related]
15. Residual tumor model in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy: Frequently involves the mucosa and/or submucosa.
Gao L; Hong ZN; Wu L; Yang Y; Kang M
Front Immunol; 2022; 13():1008681. PubMed ID: 36569913
[TBL] [Abstract][Full Text] [Related]
16. Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional Scores.
Feng J; Wang L; Yang X; Chen Q; Cheng X
J Inflamm Res; 2022; 15():3783-3796. PubMed ID: 35832830
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of MRI-based radiomics signatures models for prediction of disease-free survival and overall survival in patients with esophageal squamous cell carcinoma.
Chu F; Liu Y; Liu Q; Li W; Jia Z; Wang C; Wang Z; Lu S; Li P; Zhang Y; Liao Y; Xu M; Yao X; Wang S; Liu C; Zhang H; Wang S; Yan X; Kamel IR; Sun H; Yang G; Zhang Y; Qu J
Eur Radiol; 2022 Sep; 32(9):5930-5942. PubMed ID: 35384460
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
[TBL] [Abstract][Full Text] [Related]
19. CT radiomics in the identification of preoperative understaging in patients with clinical stage T1-2N0 esophageal squamous cell carcinoma.
Zhao B; Yan S; Jia ZY; Zhu HT; Shi YJ; Li XT; Qu JR; Sun YS
Quant Imaging Med Surg; 2023 Dec; 13(12):7996-8008. PubMed ID: 38106287
[TBL] [Abstract][Full Text] [Related]
20. A novel immune-nutritional score predicts response to neoadjuvant immunochemotherapy after minimally invasive esophagectomy for esophageal squamous cell carcinoma.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Front Immunol; 2023; 14():1217967. PubMed ID: 37954582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
